Prion Diseases¶
Chapter 449 | Part 13: Neurologic Disorders
KEY CLINICAL POINTS¶
- Prion diseases are caused by misfolded prion proteins (PrPSc) that propagate by converting normal PrPC into pathological conformations.
- Sporadic CJD (sCJD) accounts for ~85% of human prion disease cases, while genetic forms account for 10–15%.
- Variant CJD (vCJD) is linked to BSE-contaminated beef and presents with psychiatric symptoms followed by neurological decline.
- Diagnostic criteria include rapid cognitive decline, myoclonus, and MRI findings of cortical ribboning with DWI/ADC hyperintensity.
- Prion diseases are resistant to standard sterilization methods, requiring specialized decontamination protocols.
1. DEFINITION & OVERVIEW¶
Prion diseases are transmissible, protein-only pathogens that cause neurodegeneration through abnormal folding of the prion protein (PrP). These include Creutzfeldt-Jakob disease (CJD), variant CJD (vCJD), and other prion disorders in humans and animals.
Table 449-1 Glossary of PrP Prion Terminology¶
| Term | Definition |
|---|---|
| Prion | Proteinaceous infectious particle lacking nucleic acid |
| PrPSc | Scrapie isoform of prion protein; disease-causing form |
| PrPC | Cellular isoform of prion protein; precursor of PrPSc |
| PrP 27-30 | Fragment of PrPSc generated by proteolysis |
| PRNP | Gene encoding the prion protein on chromosome 20 |
1.1 Prion Protein Conformations¶
PrPC (normal) and PrPSc (pathological) are isoforms of the prion protein. PrPSc is resistant to proteolysis and forms amyloid fibrils. Prion strains exhibit distinct biological properties based on conformational differences.
1.2 Disease Spectrum¶
Human prion diseases include sporadic CJD (sCJD), genetic CJD (familial CJD), iatrogenic CJD (iCJD), and variant CJD (vCJD). Animal prion diseases include scrapie, BSE, and CWD.
2. EPIDEMIOLOGY¶
sCJD incidence: ~1–2 cases per million population. vCJD primarily affects young adults in Europe. iCJD occurs due to medical procedures like dura mater grafts or hGH contamination.
Table 449-2 The PrP Prion Diseases¶
| Disease | Host | Mechanism of Pathogenesis |
|---|---|---|
| Creutzfeldt-Jakob Disease (CJD) | Human | PrPSc accumulation in CNS |
| Variant CJD (vCJD) | Human | BSE prion transmission via beef |
| Scrapie | Sheep/Goats | Genetically susceptible hosts |
| Bovine Spongiform Encephalopathy (BSE) | Cattle | Prion-contaminated feed |
| Chronic Wasting Disease (CWD) | Deer/Elk | Prion transmission via bodily fluids |
2.1 Geographic Distribution¶
vCJD is endemic in the UK and France. CWD is prevalent in North America and Scandinavia. BSE outbreaks occurred in the UK in the 1980s.
2.2 Genetic Risk Factors¶
Codon 129 polymorphisms (M/V) influence disease susceptibility. VV genotype correlates with vCJD and longer incubation periods.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Prion diseases arise from misfolding of PrPC into PrPSc, which acts as a template for further conversion. Strain-specific conformations determine clinical phenotypes.
Table 449-3 Distinct Prion Strains Generated in Humans¶
| Inoculum | Host Species | PrP Genotype | Incubation Time (days) | PrPSc (kDa) |
|---|---|---|---|---|
| None | Human (FFI) | D178N, M129 | 206 ± 7 | 19 |
| FFI fi Tg(MHu2M) | Mouse | Tg(MHu2M) | 136 ± 1 | 19 |
| None | Human (fCJD) | E200K | 170 ± 2 | 21 |
| fCJD fi Tg(MHu2M) | Mouse | Tg(MHu2M) | 167 ± 3 | 21 |
3.1 Prion Strain Diversity¶
Strains differ in incubation time, neuropathology, and prion protein conformation (e.g., type 1 vs. type 2 PrPSc).
3.2 Species Barrier¶
Prion transmission between species depends on sequence similarity between host and donor PrP. PrPSc acts as a template for new prion formation.
4. CLINICAL FEATURES¶
CJD presents with rapid cognitive decline, myoclonus, and ataxia. vCJD has an early psychiatric prodrome followed by neurological symptoms. GSS and FFI have distinct clinical patterns.
4.1 sCJD Presentation¶
Rapid dementia, myoclonus, ataxia, and visual disturbances. MRI shows cortical ribboning with DWI/ADC hyperintensity.
4.2 vCJD Presentation¶
Early psychiatric symptoms (depression, anxiety), followed by ataxia, sensory symptoms, and dementia. Mean age of onset: 28 years.
5. DIFFERENTIAL DIAGNOSIS¶
Distinguish from AD, DLB, corticobasal degeneration, and autoimmune encephalitis. MRI and CSF biomarkers (14-3-3, tau) help differentiate prion disease from other NDs.
5.1 Mimicking Conditions¶
Dementia with Lewy bodies (DLB), AD, autoimmune encephalitis, and infections like neurosyphilis or HIV encephalopathy.
5.2 MRI Findings¶
DWI/ADC hyperintensity in cortex/striatum for sCJD vs. FLAIR hyperintensity in white matter for vasculitis.
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnosis relies on clinical features, MRI, CSF biomarkers (14-3-3, tau), and RT-QuIC assay. Brain biopsy confirms PrPSc detection.
6.1 Diagnostic Criteria¶
Rapid cognitive decline, myoclonus, and MRI findings (cortical ribboning) are key. CSF 14-3-3 and tau elevation supports diagnosis.
6.2 RT-QuIC and PMCA¶
Amyloid fibril detection using thioflavin fluorescence or PMCA amplification improves diagnostic sensitivity for prion diseases.
7. MANAGEMENT & TREATMENT¶
No curative treatment exists. Symptomatic management includes anticonvulsants, sedatives, and supportive care. Experimental therapies include quinacrine and anti-PrP antibodies.
7.1 Supportive Care¶
Manage seizures, psychiatric symptoms, and complications of dementia. Palliative care is the mainstay.
7.2 Experimental Therapies¶
Quinacrine, pentosan polysulfate, and anti-PrP antibodies show limited efficacy in preclinical models.
8. PROGNOSIS & COMPLICATIONS¶
sCJD typically results in death within 6–12 months. vCJD has a longer survival but is still fatal. Complications include autonomic dysfunction, motor neuron involvement, and prion transmission risks.
8.1 Survival Rates¶
sCJD: 6–12 months; vCJD: 1–5 years; GSS: 5 years; FFI: <2 years.
8.2 Transmission Risks¶
iCJD and vCJD can be transmitted via blood transfusions, surgical instruments, or contaminated medical devices.
9. SPECIAL CONSIDERATIONS¶
Prion diseases require strict decontamination protocols. Genetic counseling is essential for families with PRNP mutations. Blood donation restrictions apply for vCJD patients.
9.1 Decontamination¶
Autoclaving at 134°C for 5 hours or 2N NaOH treatment is recommended for prion-contaminated materials.
9.2 Genetic Counseling¶
PRNP mutations (e.g., E200K, D178N) increase risk of familial CJD. Genetic testing is critical for diagnosis.
10. KEY POINTS & CLINICAL PEARLS¶
- Prion diseases are transmissible, protein-only pathogens with no nucleic acid.
- sCJD is the most common form, while vCJD is linked to BSE-contaminated beef.
- MRI findings (cortical ribboning) and CSF biomarkers (14-3-3, tau) are diagnostic.
- No effective treatment exists; management is palliative.
- Strict decontamination protocols are required to prevent prion transmission.